- Home
- TAK vs COR Comparison
TAK vs COR Comparison
Compare TAK & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TAK | COR |
|---|---|---|
| Founded | 1781 | 2001 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.6B | 59.9B |
| IPO Year | 2007 | 2001 |
Fundamental Metrics
Financial Performance| Metric | TAK | COR |
|---|---|---|
| Price | $18.28 | $320.58 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $390.62 |
| AVG Volume (30 Days) | ★ 2.1M | 1.2M |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.24% | 0.77% |
| EPS Growth | N/A | ★ 5.71 |
| EPS | N/A | ★ 15.21 |
| Revenue | N/A | ★ $321,332,819,000.00 |
| Revenue This Year | $0.16 | $8.89 |
| Revenue Next Year | $1.22 | $6.75 |
| P/E Ratio | $41.25 | ★ $21.26 |
| Revenue Growth | N/A | ★ 9.31 |
| 52 Week Low | $12.99 | $244.82 |
| 52 Week High | $18.90 | $377.54 |
Technical Indicators
Market Signals| Indicator | TAK | COR |
|---|---|---|
| Relative Strength Index (RSI) | 54.56 | 50.98 |
| Support Level | $17.87 | $299.49 |
| Resistance Level | $18.51 | $326.95 |
| Average True Range (ATR) | 0.20 | 5.82 |
| MACD | -0.04 | -0.92 |
| Stochastic Oscillator | 19.32 | 35.97 |
Price Performance
Historical ComparisonAbout TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
About COR Cencora Inc.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.